abstract |
The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein R 1 to R 5 have any of the meanings defined in the above description; It relates to pharmaceutical compositions containing them and their use in the treatment of cell proliferative disorders. [Selection figure] None |